Abstracts - faqs.org

Abstracts

Pharmaceuticals and cosmetics industries

Search abstracts:
Abstracts » Pharmaceuticals and cosmetics industries

The cross-talk between nitric oxide and Ca2+: a story with a complex past and a promising future

Article Abstract:

The interaction between Ca2+ and nitric oxide (NO) is not mere dependence but a true, bidirectional cross-talk. The complex interaction between the Ca2+ and NO-cGMP signalling systems present an example of Ca2+ regulated cross-talk which is continuously active at different sites. Ca2+ and NO are both involved in the control of cell homeostasis. Ca2+ levels in smooth muscles and platelets are controlled by cGMP levels. The effects of NO are also influenced by cGMP through the activation of cytosolic cGMP-dependent protein kinase 1.

Author: Meldolesi, Jacopo, Clementi, Emilio
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1997
Cellular control mechanisms, Cell regulation, Second messengers (Biochemistry), Second messengers (Cytochemistry), Homeostasis

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


NO-aspirins: a class of new anti-inflammatory and antithrombotic agents

Article Abstract:

Nitroaspirins are a new class of anti-inflammatory agents that combine the release of nitric oxide (NO) with the inhibition of cyclooxygenase (COX). The release of NO ensures gastrointestinal safety and explains the ability of these agents to interfere with pathological processes. The toxicity of these agents, however, is largely due to the inhibition of COX, a process that helps many of the pharmacological and therapeutic effects of aspirins.

Author: Soldato, Piero del, Sorrentino, Raffaella, Pinto, Aldo
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1999
Aspirin, Fibrinolytic agents, Anti-inflammatory drugs, Anti-inflammatory agents, Thrombolytic drugs

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Nitric oxide, glial cells and neuronal degeneration in parkinsonism

Article Abstract:

Nitric oxide produced by glial cells may be responsible for destroying neurons in patients with Parkinson's disease. A drug that blocks the activity of the inducible form of nitric oxide synthase may prevent this destruction.

Author: Hirsch, Etienne C., Hunot, Stephane
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 2000
Nervous system, Parkinson's disease, Parkinson disease, Nerve degeneration

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, Physiological aspects, Nitric oxide
Similar abstracts:
  • Abstracts: INCI names: differences between the US and the EU. Notes from Latin America. Triglycerides: A Primary Ingredient for Making Surfactants
  • Abstracts: This and that: creatine's superfluous methyl and the shadowed art of Cimabue. This and that: the fire of Galileo's imagination and putting teeth into toxicology
  • Abstracts: Recent developments with neuropeptide Y receptor antagonists. The role of neuropeptide Y in cardiovascular regulation
  • Abstracts: Disclosing apoptosis in the CNS. Neuronal cell death: a demise with different shapes. Mechanism of tetanus toxin in neuronal cell death
  • Abstracts: Asthma therapy for the 21st century. NF-kB: a pivotal role in asthma and a new target for therapy. Reply: 5-HT(sub)1A receptors and control of airways
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.